Mesotherapy is a non-surgical hair loss treatment that delivers a customised blend of active compounds — vitamins, amino acids, peptides, hyaluronic acid, and where clinically indicated, DHT-blocking medications — directly into the scalp via microinjections at a depth of 1–4mm. By bypassing the skin barrier entirely, mesotherapy delivers therapeutic agents at follicle level with greater precision and lower doses than topical or oral administration. At Hair of Istanbul, scalp mesotherapy is administered by Dr Hayriye Dilber under full clinical assessment and medical supervision.
Mesotherapy was developed in France in 1952 by Dr Michel Pistor and recognised by the French Academy of Medicine in 1987. For hair loss, mesotherapy involves injecting a tailored solution of bioactive compounds into the scalp’s mesodermal layer at 1–4mm depth — directly into the environment that surrounds and supports hair follicles. This approach bypasses the epidermal barrier that limits topical treatment absorption and avoids the systemic circulation that causes side effects with oral medications.
A 2023 systematic review by Gupta et al. (Journal of Dermatological Treatment) identified 27 studies evaluating mesotherapy for hair loss, covering 6 classes of agents: dutasteride, minoxidil, growth factors, botulinum toxin A, stem cells, and multivitamin solutions. Multiple studies report statistically significant improvements in hair growth. A large real-world retrospective study by Saceda-Corralo et al. (2022, n=541) found 38.4% of patients showed marked improvement with dutasteride mesotherapy at 12 months — with zero serious or sexual adverse events across the entire cohort.
Mesotherapy injections reach the scalp mesodermal layer at 1–4mm depth — directly at the level of follicle blood vessels and structural support cells. Active compounds are delivered where topical agents cannot reliably penetrate.
When dutasteride is delivered via mesotherapy, follicle-level concentration is achieved at a fraction of the oral dose — remaining localised in the scalp. Saceda-Corralo et al. 2022 (n=541) confirmed zero sexual adverse events with local dutasteride delivery.
At Hair of Istanbul, the mesotherapy solution is tailored to each patient's hair loss cause and scalp condition. Core ingredients include hyaluronic acid, biotin (B7), vitamins B6 and B12, amino acids, zinc gluconate, peptides, and medical-grade growth factors.
Mesotherapy is fully compatible with hair transplant surgery, PRP, exosome therapy, and red light therapy. Combined protocols are consistently more effective than any single treatment alone and are designed individually at Hair of Istanbul.
Hair loss stage, cause, and scalp condition assessed. Dr Hayriye Dilber selects the appropriate mesotherapy formulation — multivitamin, peptide-based, or medication-containing (dutasteride/minoxidil) — based on clinical indication and patient history.
Trichoscopic evaluation of density and miniaturisation. Medical history reviewed — contraindications, current medications, allergy history confirmed. Cardiovascular assessment by Dr Hayriye Dilber where indicated. Treatment plan confirmed.
Weekly sessions of 15–30 minutes each. Fine-needle microinjections deliver the custom cocktail into the scalp mesodermal layer. Mild redness resolves within 24–48 hours. Normal activities resumed same day.
Reduced daily shedding is typically the first change noticed. Scalp hydration and condition improve visibly. Follicle environment is being progressively optimised with each session.
Sessions spaced to every 2–4 weeks as the initial protocol progresses. Visible improvements in density, hair shaft thickness, and hair quality become apparent. Dutasteride mesotherapy effects on DHT accumulate with each session.
Maintenance sessions every 3–6 months sustain results. Saceda-Corralo et al. 2022 (n=541) documented 38.4% marked improvement at 12 months with zero serious adverse events. Combined protocols with PRP or exosome therapy extend results further.
Resume normal activities immediately. Avoid washing the scalp for 8–12 hours after each session. Mild redness, sensitivity, or small bumps at injection sites are normal and resolve within 24–48 hours.
Resume normal washing with gentle, sulphate-free shampoo. Avoid direct sunlight, saunas, steam rooms, and swimming pools for 3–5 days after each session.
Maintain scalp hygiene as normal. Avoid topical products with high alcohol content or harsh preservatives on the treatment area between sessions. Continue any concurrent medical treatments as prescribed.
Reduced shedding is typically the first observable sign of response. Hair on the pillow and in the shower decreases. Scalp condition — hydration, sensitivity, sebum balance — visibly improves.
Visible improvements in density and hair shaft thickness begin. In protocols including dutasteride or minoxidil, the cumulative DHT-blocking or vasodilatory effect builds with each subsequent session.
Mesotherapy results are not permanent — the follicle environment requires ongoing maintenance. Sessions every 3–6 months sustain the biological benefits. Combined protocols with hair transplant, PRP, or exosome therapy produce the most durable outcomes.
Mesotherapy is appropriate for men and women with androgenetic alopecia, telogen effluvium, or other forms of hair thinning where the follicle environment is compromised by nutritional deficiency, poor scalp circulation, or DHT-driven miniaturisation. It is particularly valuable for patients who cannot tolerate systemic DHT blockers, those seeking to support scalp health non-pharmacologically, and patients using mesotherapy as part of a multi-modal protocol alongside hair transplant surgery or other regenerative treatments.
Patients with Norwood I–IV (men) or Ludwig I–II (women) with active miniaturisation are the strongest candidates. Mesotherapy is most effective when follicles remain biologically viable — early intervention preserves more active follicles.
Acute or chronic telogen effluvium — from stress, nutritional deficiency, hormonal disruption, or post-partum changes — responds well to vitamin and peptide-based mesotherapy, which directly supports follicle cycling recovery and scalp health.
Mesotherapy applied in the weeks following hair transplant surgery nourishes the scalp environment, supports graft survival, and addresses miniaturisation in the native hair surrounding the transplant zone — a clinically sound complement to surgical restoration.
For patients who wish to address DHT-driven hair loss but cannot or prefer not to take oral finasteride or dutasteride systemically, localised dutasteride mesotherapy achieves follicle-level DHT suppression at a fraction of the oral dose — with a confirmed minimal systemic side effect profile.
Hair mesotherapy delivers a customised blend of vitamins, amino acids, peptides, hyaluronic acid, and where clinically indicated, DHT-blocking medications (dutasteride, minoxidil) via fine-needle microinjections into the scalp at 1–4mm depth. By bypassing the epidermal barrier and avoiding systemic circulation, mesotherapy places active compounds directly at the level of follicle blood vessels and support cells — improving scalp circulation, delivering targeted nutrition, reducing DHT locally, and stimulating the follicle growth environment.
The mesotherapy formulation is tailored to each patient’s specific hair loss cause, scalp condition, and clinical indication by Dr Hayriye Dilber. The base cocktail includes hyaluronic acid, biotin (B7), vitamins B6 and B12, amino acids (proline, glycine, cysteine), zinc gluconate, and medical-grade peptides and growth factors. For patients with androgenetic alopecia driven by DHT, the formulation may include dutasteride at 0.01% concentration or minoxidil — delivered locally to avoid systemic side effects.
Localised dutasteride delivered via mesotherapy operates at a far lower dose than oral administration. A large real-world retrospective study by Saceda-Corralo et al. (2022, n=541 patients, 12 months) found 38.4% of patients showed marked improvement — with zero serious adverse events and zero sexual side effects recorded across the entire cohort. The local delivery mechanism keeps the drug concentrated in the scalp rather than circulating systemically, which is why the side effect profile differs significantly from oral dutasteride.
A full initial protocol at Hair of Istanbul consists of 6–12 sessions: weekly for the first 4–8 weeks, then every 2–4 weeks as the protocol progresses. Maintenance sessions every 3–6 months sustain results. The number of sessions depends on the hair loss stage, the chosen formulation, and whether mesotherapy is used as a standalone treatment or part of a combined protocol.
Most patients notice reduced daily shedding within the first 4–8 weeks. Visible improvements in hair density and shaft thickness typically become apparent from months 2–3. In dutasteride or minoxidil protocols, the cumulative DHT-blocking or vasodilatory effect builds progressively with each session. Full results from a complete initial course are typically visible at 6–12 months. Mesotherapy results are not permanent — maintenance sessions are required to sustain the outcome.
The three treatments operate through complementary but distinct mechanisms. PRP delivers concentrated growth factors from the patient’s own platelets. Exosome therapy delivers a standardised, high-concentration payload of growth factors and RNA from stem cell-derived vesicles. Mesotherapy delivers customised active compounds — including vitamins, amino acids, hyaluronic acid, and where indicated, DHT-blocking medications — directly into the scalp environment. All three can be combined and are regularly used together in multi-modal protocols at Hair of Istanbul.
No. Fine-gauge needles are used for all scalp injections, and most patients tolerate mesotherapy without anaesthesia. Topical numbing cream is available for patients who prefer it. Most patients describe mild stinging or a brief scratching sensation during the injections, which resolves immediately. Mild redness and sensitivity at injection sites are normal and resolve within 24–48 hours.
Scalp mesotherapy at Hair of Istanbul is administered by Dr Hayriye Dilber, who manages the pre-treatment assessment, formulation selection, cardiovascular review, and all injection sessions. All mesotherapy treatments take place within the clinical environment at Hair of Istanbul under full physician supervision.
Get in touch for a free consultation. Our multilingual team is ready to answer your questions and guide you through the process.
Fill out the form and our team will contact you within 24 hours.